COMPASSION 3: Congenital Multicenter Trial of Pulmonic Valve Dysfunction Studying the

Grants and Contracts Details

StatusActive
Effective start/end date9/7/1610/1/22

Funding

  • Edwards Lifesciences: $65,176.00